- Published at
- by seekingalpha.com
neutral
neutral
Qualigen to invest in NanoSynex, stock tumbles 21% (QLGN:NASDAQ)
Qualigen Therapeutics (QLGN) stock fell 21% after announcing participation in a funding round for Israeli medtech NanoSynex. Read more here.